Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-94.06%Cash Return on Invested Capital
VS
Market
Sector
Industry
History
$ 0.76Close
$ 0.65 - $ 1.48 52-Week Range
Ticker Information
Ticker
XLOCompany Name
XILIO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQXILIO THERAPEUTICS INC - Cash Return on Invested Capital Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
XLO - CROIC Historical data
| Date | Cash Return on Invested Capital | Free Cash Flow | Invested Capital |
|---|---|---|---|
| 6/30/2025 | -94.06% | $ -13.77M | $ 14.63M |
| 3/31/2025 | 113.36% | $ 21.04M | $ 18.56M |
| 12/31/2024 | -71.54% | $ -18.41M | $ 25.74M |
| 9/30/2024 | -60.15% | $ -17.68M | $ 29.39M |
| 6/30/2024 | -41.25% | $ -17.37M | $ 42.1M |
| 3/31/2024 | -156.12% | $ -54.19M | $ 34.71M |
| 12/31/2023 | -140.09% | $ -69.11M | $ 49.33M |
| 9/30/2023 | -111.25% | $ -74.41M | $ 66.88M |
| 6/30/2023 | -96.55% | $ -81.28M | $ 84.19M |
| 3/31/2023 | -79.61% | $ -81.92M | $ 102.9M |
Key Performance Insights, Last 5 Years
- XILIO THERAPEUTICS INC's latest trailing twelve months (TTM) CROIC stands at 0%.
- Over the past 5 years, XILIO THERAPEUTICS INC's average CROIC has been -66.99%.
- The median CROIC for XILIO THERAPEUTICS INC during this period was -66.66%
- XILIO THERAPEUTICS INC reached its highest CROIC over the past 5 years at 113.36%.
- The lowest CROIC recorded by XILIO THERAPEUTICS INC in the same timeframe -156.12%
XILIO THERAPEUTICS INC's CROIC vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CROIC Benchmarks
Similar metrics to Inv. Capital:
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
- Invested Capital - [Calculation] Invested Capital is the total amount of money raised by a business in the form [Equity] and/or [Debt].
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Capital Expenditures Margin - [Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
Definition of Cash Return on Invested Capital
[Calculation] Cash Return on Invested Capital (CROIC) measures how well a company uses its invested capital to produce cash. It is calculated as Free Cash Flow [FCF] divided by invested capital [InvCapital].FCF / Inv. Capital
(=) CROIC CROIC for XILIO THERAPEUTICS INC is calculated as follows: FCF [ $ -38.28M ] / Inv. Capital [ $ -62.07M ]
(=) CROIC [ 0% ] XLO - Cash Return on Invested Capital, Last 5 years
-156.12%
Minimum
Mar 31, 2024
113.36%
Maximum
Mar 31, 2025
-66.99%
Average
-66.66%
Median
CROIC Benchmark AnalysisMarket
The chart above depicts the distribution of CROIC for companies in the Total Stock Market. The average CROIC of the companies is 2.8% with a standard deviation of 15%.
The following table provides additional summary stats:
CROIC in the Market:
| filtered constituents | 3.46K |
|---|---|
| min | -43.7% |
| max | 49.3% |
| average | 2.8% |
| median | 4.99% |
| std | 15% |